Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Roche renewed the licensing agreement of Genedata Expressionist for Mass Spectrometry. Genedata Expressionist is a comprehensive, enterprise-level system for omics data management. Roche will use the system to target molecular pathways and validate novel biomarkers in the field of proteomics.

Thriving on large experimental data sets, Genedata Expressionist for Mass Spectrometry integrates a range of mass spectrometry (MS) technologies including label-free LC-MS/GC-MS, labeled experiments using SILAC, iTRAQ, and TMT, MRM, and Infusion MS. It also provides a rich portfolio of statistical tools that promote understanding of biological systems and diseases. Workflow support includes:

"Using Genedata Expressionist helps us to efficiently support the complex data flow and analysis of the mass spectrometry experiments. Our experience with the software and the company is positive," noted Dr. Martin Erkens, head of Early Development Informatics, pRED.

"Roche is pioneering personalized healthcare and we take great pride in contributing to this innovative work," said Dr. Othmar Pfannes, CEO of Genedata. "Moreover, Roche's use of Genedata Expressionist validates it as the platform of choice for integrated, large-scale data management in biomarker discovery for personalized healthcare."

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

Exclusive articles

Presentations from international conferences

Over 2,400+ scientific posters on ePosters

More than 3,700+ scientific videos on LabTube

35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.